The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial-Reference-Cited by-同舟云学术

The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial

Published:2018-09-09 Issue:5 Volume:89 Page:605-612
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Davis Susan R.¹,Robinson Penelope J.¹,Jane Fiona¹,White Shane²,Brown Kristy A.³,Piessens Sofie⁴,Edwards Andrew⁴,McNeilage Jane⁵,Woinarski Jillian⁵,Chipman Mitchell⁶,Bell Robin J.¹

Affiliation:

1. Women's Health Research Program; School of Public Health and Preventive Medicine; Monash University; Melbourne Victoria Australia

2. Austin Health; Olivia Newton-John Cancer Centre; Heidelberg Victoria Australia

3. Weill Cornell Medicine; New York City New York

4. Camberwell Ultrasound for Women; Melbourne Victoria Australia

5. Epworth Healthcare; East Melbourne Victoria Australia

6. Victorian Breast & Oncology Care; East Melbourne Victoria Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13830/fullpdf

Reference37 articles.

1. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: Atlas, a randomised trial;Davies;Lancet,2013

2. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer;Deligdisch;Gynecol Oncol,2000

3. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound;Gerber;J Clin Oncol,2000

4. Endometrial effects of exemestane compared to tamoxifen within the tamoxifen exemestane adjuvant multicenter (team) trial: results of a prospective gynecological ultrasound substudy;Kieback;Gynecol Oncol,2010

5. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive cancer centres’ alert group. Assessment of liver and endometrial cancer risk following tamoxifen;Bergman;Lancet,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin use and risk of myeloproliferative neoplasms: a Danish population–based case-control study;Blood Advances;2024-08-27

2. Exploring the inhibitory impact of Mongolian medicinal He-Zi-3 soup on mammary gland hyperplasia in rats induced by estrogen and progestogen;Journal of Ethnopharmacology;2024-07

3. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2024-03-11

4. Pharmacokinetic study of multicomponent in Hong‐Hua‐Xiao‐Yao tablet;Biomedical Chromatography;2024-03-06

5. The Survival Effect of Metformin on Non-Small Cell Lung Cancer Treated with Chemotherapy: A Systematic Review;Journal of Clinical Pharmacy and Therapeutics;2023-07-03